Minimizing Tumor Volume for a Mathematical Model of Anti-Angiogenesis with Linear Pharmacokinetics

Optimal and suboptimal protocols are given for a mathematical model for tumor anti-angiogenesis. If a linear model for the pharmacokinetics of the antiangiogenic agent is included in the modeling, optimal controls have chattering arcs, but excellent suboptimal approximations can be given.

[1]  L. Wein,et al.  Optimal scheduling of radiotherapy and angiogenic inhibitors , 2003, Bulletin of mathematical biology.

[2]  Urszula Ledzewicz,et al.  Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment. , 2010, Mathematical medicine and biology : a journal of the IMA.

[3]  I. B. Borel Rinkes,et al.  Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. , 2000, Cancer research.

[4]  A. Friedman.  Cancer Models and Their Mathematical Analysis , 2006 .

[5]  Urszula Ledzewicz,et al.  No . 4 B Singular controls and chattering arcs in optimal control problems arising in biomedicine , 2010 .

[6]  E. Afenya.  Using mathematical modeling as a resource in clinical trials. , 2005, Mathematical biosciences and engineering : MBE.

[7]  U. Ledzewicz,et al.  The influence of pk/pd on the structure of optimal controls in cancer chemotherapy models. , 2005, Mathematical biosciences and engineering : MBE.

[8]  V. Boltyanskii.  Sufficient Conditions for Optimality and the Justification of the Dynamic Programming Method , 1966 .

[9]  Urszula Ledzewicz,et al.  Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy. , 2007, Mathematical biosciences.

[10]  U. Ledzewicz,et al.  ANTI-ANGIOGENIC THERAPY IN CANCER TREATMENT AS AN OPTIMAL CONTROL PROBLEM , 2007 .

[11]  Urszula Ledzewicz,et al.  AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem , 2007, SIAM J. Control. Optim..

[12]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[13]  H. Maurer,et al.  Optimization methods for the verification of second order sufficient conditions for bang–bang controls , 2005 .

[14]  Richard Bellman,et al.  Introduction to the mathematical theory of control processes , 1967 .

[15]  Urszula Ledzewicz,et al.  Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models , 2009 .

[16]  Vladimir Borisov,et al.  Theory of Chattering Control , 1994 .

[17]  R. D'Amato,et al.  Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. , 2001, Cancer research.

[18]  A. Fuller.  Study of an Optimum Non-linear Control System† , 1963 .

[19]  D. Wishart.  Introduction to the Mathematical Theory of Control Processes. Volume 1—Linear Equations and Quadratic Criteria , 1969 .

[20]  M. I. Zelikin,et al.  Theory of Chattering Control: with applications to Astronautics, Robotics, Economics, and Engineering , 1994 .

[21]  J. P. Mcdanell,et al.  Necessary Conditions Joining Optimal Singular and Nonsingular Subarcs , 1971 .

[22]  H. Schättler,et al.  A Synthesis of Optimal Controls for a Model of Tumor Growth under Angiogenic Inhibitors , 2005, Proceedings of the 44th IEEE Conference on Decision and Control.

[23]  M. Chyba,et al.  Singular Trajectories and Their Role in Control Theory , 2003, IEEE Transactions on Automatic Control.